| Literature DB >> 35299645 |
Jianghui Qin1, Fang Chen2, Pingli Wu1, Guoming Sun2.
Abstract
Wound healing is an evolved dynamic biological process. Though many research and clinical approaches have been explored to restore damaged or diseased skin, the current treatment for deep cutaneous injuries is far from being perfect, and the ideal regenerative therapy remains a significant challenge. Of all treatments, bioengineered scaffolds play a key role and represent great progress in wound repair and skin regeneration. In this review, we focus on the latest advancement in biomaterial scaffolds for wound healing. We discuss the emerging philosophy of designing biomaterial scaffolds, followed by precursor development. We pay particular attention to the therapeutic interventions of bioengineered scaffolds for cutaneous wound healing, and their dual effects while conjugating with bioactive molecules, stem cells, and even immunomodulation. As we review the advancement and the challenges of the current strategies, we also discuss the prospects of scaffold development for wound healing.Entities:
Keywords: bioengineered scaffolds; biomaterials; pro-regenerative; skin; wound healing
Year: 2022 PMID: 35299645 PMCID: PMC8921732 DOI: 10.3389/fbioe.2022.841583
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1Cutaneous wound healing treated with tissue-engineered scaffolds. The wounds are currently treated either with typical biological scaffolds or pro-regenerative ones. Though both scaffolds facilitate wound healing, the pro-regenerative scaffolds bring about more complete skin structures, while the traditional biological scaffolds mostly lead to scarred skin.
Natural biomaterials of bioengineered scaffolds.
| Materials | Method | Highlight | Biomedical application | Ref |
|---|---|---|---|---|
| Alginate | Pressurized gas expanded liquid (PGX) technology | Increased surface areas | The scaffolds can be leveraged to load clinically-relevant and highly bioavailable dosages of hydrophobic drugs in hydrogels |
|
| High drug loadings | ||||
| Accelerated burn wound healing | ||||
| Alginate | Microfluidic technology | Biocompatibility | The scaffolds ideally meet the requirements for different stages in a full-thickness skin wound model of rats |
|
| Biodegradability | ||||
| Stimulate angiogenesis | ||||
| Higher granulation tissue thickness | ||||
| Alginate/Chitosan | Interpolymer complexation | Highly porous | The scaffold helps in quick recovery from diabetic wounds by coordinating angiogenesis and inflammation |
|
| Good thermal stability | ||||
| Enhanced water uptake | ||||
| Controlled degradation | ||||
| Chitosan/PI | Freezing/thawing approach | Low cytotoxicity | The hydrogel-based patches allowed the acceleration of wound healing in rats’ models and the complete healing |
|
| Drugs-control release | ||||
| Antioxidant abilities | ||||
| Enhanced angiogenesis | ||||
| Chitosan/OD | Chemical crosslinking | Coagulate heparinized | The scaffold has potential for hemorrhagic and infected wound healing in an infected wound model of rat skin |
|
| Hemostatic activity | ||||
| Antibacterial activity | ||||
| Low cytotoxicity | ||||
| Chitosan/CMs | Electro-spinning | High wettability | The scaffolds provided an easy and rapid continuous large-scale industrial design strategy for natural bioresource-based wound dressing materials |
|
| Hydrophilicity | ||||
| Gas permeability | ||||
| Antibacterial activity | ||||
| Collagen | Chemical crosslinking | Facilitate angiogenesis | The scaffold helps in quick recovery from diabetic wounds by managing angiogenesis and inflammation |
|
| Reduce inflammation | ||||
| ECM accumulation | ||||
| Re-epithelialization | ||||
| HA/CCS/HLC | Chemical crosslinking | Non-toxic | The scaffold had an excellent repair effect on deep second-degree burns |
|
| Biodegradability | ||||
| Help cell proliferation | ||||
| Fibrin | Chemical crosslinking | Biocompatibility | The SVF-based full-thickness skin grafts are safe and accelerate the wound healing process |
|
| Increase skin thickness | ||||
| Promote cell migration | ||||
| Cellulose acetate | Electro-spinning | Good cell adhesion | The scaffold provides good cell adhesion and proliferation towards NIH 3T3 fibroblast and HaCaT cells |
|
| Fluorescence properties | ||||
| Help cell proliferation | ||||
| Excellent porosity | ||||
| Cellulose/curcumin | Electro-spinning | Biocompatibility, Hydrophilicity | The scaffold confirms the potential of using sugarcane by-products in the design of scaffolds for skin tissue engineering |
|
| Pre-vascularization | ||||
| Support cell growth | ||||
| CMC |
| Good thermal sensitivity | The scaffold provides a new strategy for future flexible and wearable temperature sensing devices |
|
| Excellent mechanical | ||||
| Self-healing properties | ||||
| SF | 3D bioprinting | Biocompatibility | The silk fibroin hydrogels could be used for nerve tissue engineering and wound healing |
|
| Mechanical stability | ||||
| Printability | ||||
| SF/TA | Mixing | Adjustable viscoelasticity | The hydrogel could adhere to the skin surface as a flexible wearable strain sensor |
|
| Antibacterial properties | ||||
| Self-healing | ||||
| Sf/borosilicate | UV crosslinking | Enhanced angiogenesis | The hydrogel could be used to regenerate diabetic wounds |
|
| Antibacterial properties | ||||
| Reduce inflammation |
PI, protein isolate; OD, oxidized dextran; CMs, cellulose membranes; HA, hyaluronic acid; CCS, carboxylated chitosan; HLC, human-like collagen; SVF, stromal vascular fraction; CMC, carboxymethyl cellulose; TA, tannic acid; SF, silk fibroin.
Synthetic materials of bioengineered scaffolds.
| Materials | Method | Highlight | Biomedical application | Ref |
|---|---|---|---|---|
| PVA/HNT | Dispersion mixing technique | Biocompatible | The PVA-based nanocomposite wafers can provide new and suitable wound dressings for wounds exposed to infection such as burn wounds |
|
| Anti-bacterial | ||||
| Anti-inflammatory | ||||
| PVA/DPHC | Freezing thawing method | Anti-bacterial | The PVA/DPHC hydrogels have great potential for use in wound dressings |
|
| Strong wound healing effect | ||||
| PCL/SPC | Electro-spinning technology | Vascularization | The scaffold could potentially be used as an envisioned approach for the efficient recovery of chronic diabetic wounds |
|
| Compact ECM | ||||
| Up-regulation of HIF-1α | ||||
| PCL/Alaptide/L-Arginine | Electro-spinning | Re-epithelization | The modified nanofibrous membranes are promising for treating wounds with large damaged areas |
|
| Improved wound closure | ||||
| P (TA)/p (HEMA) | Cryo-gelation technique | Antibacterial | The scaffold can be used as wound dressing material since it possesses antioxidant, antimicrobial, and blood compatibility properties |
|
| Biodegradability | ||||
| High hemostatic | ||||
| AgNPs/pSBAA | Physical crosslinking | Germicidal | The novel non-sticky and antimicrobial zwitterionic |
|
| Higher water content | The scaffold has the potential for the treatment of infected chronic wounds | |||
| Low cytotoxicity | ||||
| PVP/Cipro | Electro-spinning | Antibacterial | The scaffold showed promising wound resorption characteristics in a full-thickness excisional skin wound healing mice model |
|
| Plasticity | ||||
| Wound resorption | ||||
| PVP/PVB | Electro-spinning | Antibacterial | The scaffold produced by the |
|
| Air permeability | ||||
| PNIPAM/PAA | Chemical crosslinking | Stiffness tunable | Regulating scaffold’s stiffness affect therapeutic effects in the wound healing |
|
| ECM remodeling |
HNT, halloysite nanotubes; SPC, sodium percarbonate; DPHC, diphlorethohydroxycarmalol; PAA, poly (amidoamine); p (HEMA), poly (2-hydroxy ethyl methacrylate); AgNPs, silver nanoparticles; pSBAA, poly (sulfobetaine acrylamide); Cipro, ciprofloxacin; PVB, poly (vinyl butyral); PVP, polyvinylpyrrolidone; PNIPAM, poly (n-isopropyl acrylamide).
Natural-synthetic hybrid materials of bioengineered scaffolds.
| Materials | Method | Highlight | Biomedical application | Ref |
|---|---|---|---|---|
| Chitosan/PLGA | Chemical crosslinking | Low cytotoxicity | Improved wound healing when used in the diabetic rat model |
|
| Reduce inflammation | ||||
| Improve neovascularization | ||||
| CMCS/SA | EDC/NHS crosslinking | Antibacterial activity | The scaffold inhibited bacteria growth and promoted wound healing in the burn-infection model |
|
| Rapid epithelialization | ||||
| Higher collagen deposition | ||||
| Alginate/PVA | Solvent casting method | Good mechanical properties | The alginate-based hydrogel membrane could be an efficient wound healer for faster wound healing |
|
| Sustained release | ||||
| Granulation tissue formation | ||||
| Dextran/HA/PEI | UV light crosslinking | Biocompatible inhibiting inflammation promoting microvascular | The hydrogel system can be considered as a promising wound dressing for the treatment of various types of wounds |
|
| PVA/Dextran-aldehyde | Freeze-thaw method | Large exudate absorption | The hydrogel scaffold accelerated wound healing in full-thickness skin defect model |
|
| Suitable transmission rate biocompatibility | ||||
| PEG/fibrin | Co-polymerize | Properties adjustable | The macroporous and mechanically reinforced fibrin-based sequential IPN hydrogels useful for dermal tissue regeneration |
|
| Cellular infiltration | ||||
| Tissue remodeling |
CMCS, carboxymethyl chitosan; SA, sodium alginate; HA, hyaluronic acid; PEI, polyethyleneimine; PEG, polyethylene glycol.
FIGURE 2Immuno-engineering pro-regenerative scaffolds for wound healing. (A) Either chemically modifying precursors or regulating the physical structures enable the immunomodulatory properties of the scaffolds. (B) Constructing innate immunomodulatory biomaterials into pro-regenerative scaffolds for skin regeneration. (C) Incorporating immunomodulatory biomolecules into scaffolds to empower the regenerative capacities for wound healing.
FIGURE 3Encapsulating stem cells into scaffolds to enhance wound healing either through contributing to new tissue formation or by releasing regulating biomolecules.